The submission is focused on the test performance and safety results from more than 25,000 patients in the Pathfinder 2 study and from the first year of the NHS-Galleri study.
MedPage Today on MSN
Study questions benefit of FDA-cleared device for ADHD
The agency is currently reviewing the study findings ...
The nationwide study will assess the safety and efficacy of the technology that combines standard balloon dilation to open the nasal passageways with drug delivery designed to maintain symptom relief ...
JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients ...
A study found that 26% of uncertainties in cancer drug approvals are not included in FDA labels, with 48% being crucial to approval decisions. The FDA's current communication methods, such as drug ...
Background: Failure to detect significant drug interactions may result in adverse outcomes. While proper screening and management of drug interactions can prevent the majority of adverse events, ...
MedPage Today on MSN
Dual GIP/GLP-1 drug linked to reduced diabetic retinopathy incidence
However, concerns about the impact of rapid glycemic control on diabetic retinopathy risk ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results